No significant correlations were observed between iRhom2 protein expression in tumours and their clinicopathological features, except that high levels of iRhom2 expression were shown to correlate negatively with overall survival (P < 0.0005) (Fig. 2). The gene discussed is RHBDF2; the disease is neoplasm.